Cargando…
Light-activated nanomaterials for tumor immunotherapy
Tumor immunotherapy mainly relies on activating the immune system to achieve antitumor treatment. However, the present tumor immunotherapy used in the clinic showed low treatment efficacy with high systematic toxicity. To overcome the shortcomings of traditional drugs for immunotherapy, a series of...
Autores principales: | Wang, Fang, Duan, Huijuan, Xu, Weizhe, Sheng, Gang, Sun, Zhaogang, Chu, Hongqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585221/ https://www.ncbi.nlm.nih.gov/pubmed/36277335 http://dx.doi.org/10.3389/fchem.2022.1031811 |
Ejemplares similares
-
Macrophage-targeted nanoparticles mediate synergistic photodynamic therapy and immunotherapy of tuberculosis
por: Tian, Na, et al.
Publicado: (2023) -
Recent advances in functionalized upconversion nanoparticles for light-activated tumor therapy
por: Chu, Hongqian, et al.
Publicado: (2021) -
LRRC25 Inhibits IFN-γ Secretion by Microglia to Negatively Regulate Anti-Tuberculosis Immunity in Mice
por: Sheng, Gang, et al.
Publicado: (2023) -
Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patients
por: Cao, Tingming, et al.
Publicado: (2022) -
Real-time drug release monitoring from pH-responsive CuS-encapsulated metal–organic frameworks
por: Liu, Bei, et al.
Publicado: (2022)